CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies

Maude, 2014, Chimeric antigen receptor T cells for sustained remissions in leukemia, N Engl J Med, 371, 1507, 10.1056/NEJMoa1407222 Brentjens, 2013, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia, Sci Transl Med, 5, 177ra38, 10.1126/scitranslmed.3005930 Turtle, 2016, CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients, J Clin Invest, 126, 2123, 10.1172/JCI85309 Mamonkin, 2015, A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies, Blood, 126, 983, 10.1182/blood-2015-02-629527 Kernan, 1984, Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin, J Immunol, 133, 137, 10.4049/jimmunol.133.1.137 Sotillo, 2015, Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy, Cancer Discov, 5, 1282, 10.1158/2159-8290.CD-15-1020 Rapoport, 2015, NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma, Nat Med, 21, 914, 10.1038/nm.3910 Haynes, 1979, Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets, Proc Natl Acad Sci USA, 76, 5829, 10.1073/pnas.76.11.5829 Rabinowich, 1994, Expression and function of CD7 molecule on human natural killer cells, J Immunol, 152, 517, 10.4049/jimmunol.152.2.517 Campana, 1991, Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia, Blood, 77, 1546, 10.1182/blood.V77.7.1546.1546 Gorczyca, 2014, Atlas of Differential Diagnosis in Neoplastic Hematopathology, 3rd ed Ward, 1995, Antibody ligation of CD7 leads to association with phosphoinositide 3-kinase and phosphatidylinositol 3,4,5-trisphosphate formation in T lymphocytes, Eur J Immunol, 25, 502, 10.1002/eji.1830250229 Chan, 1997, CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase, J Immunol, 159, 934, 10.4049/jimmunol.159.2.934 Lyman, 2000, Identification of CD7 as a cognate of the human K12 (SECTM1) protein, J Biol Chem, 275, 3431, 10.1074/jbc.275.5.3431 Bonilla, 1997, Targeted gene disruption of murine CD7, Int Immunol, 9, 1875, 10.1093/intimm/9.12.1875 Lee, 1998, Immunologic characterization of CD7-deficient mice, J Immunol, 160, 5749, 10.4049/jimmunol.160.12.5749 Preijers, 1988, Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins, Br J Haematol, 70, 289, 10.1111/j.1365-2141.1988.tb02484.x Frankel, 1997, Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin, Leuk Lymphoma, 26, 287, 10.3109/10428199709051778 Pauza, 1997, Construction and characterization of human CD7-specific single-chain Fv immunotoxins, J Immunol, 158, 3259, 10.4049/jimmunol.158.7.3259 Baum, 1996, Therapy with CD7 monoclonal antibody TH-69 is highly effective for xenografted human T-cell ALL, Br J Haematol, 95, 327, 10.1046/j.1365-2141.1996.d01-1900.x Cradick, 2014, COSMID: a Web-based tool for identifying and validating CRISPR/Cas off-target sites, Mol Ther Nucleic Acids, 3, e214, 10.1038/mtna.2014.64 Moreno-Mateos, 2015, CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo, Nat Methods, 12, 982, 10.1038/nmeth.3543 Gundry, 2016, Highly efficient genome editing of murine and human hematopoietic progenitor cells by CRISPR/Cas9, Cell Reports, 17, 1453, 10.1016/j.celrep.2016.09.092 Lee, 2017, Design and validation of CRISPR/Cas9 systems for targeted gene modification in induced pluripotent stem cells, Methods Mol Biol, 1498, 3, 10.1007/978-1-4939-6472-7_1 Cong, 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819, 10.1126/science.1231143 Tsai, 2015, GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases, Nat Biotechnol, 33, 187, 10.1038/nbt.3117 Lee, 2016, The Neisseria meningitidis CRISPR-Cas9 system enables specific genome editing in mammalian cells, Mol Ther, 24, 645, 10.1038/mt.2016.8 Lin, 2014, CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences, Nucleic Acids Res, 42, 7473, 10.1093/nar/gku402 Brentjens, 2007, Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts, Clin Cancer Res, 13, 5426, 10.1158/1078-0432.CCR-07-0674 Tebas, 2014, Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV, N Engl J Med, 370, 901, 10.1056/NEJMoa1300662 Qasim, 2015, First clinical application of Talen engineered universal CAR19 T cells in B-ALL, Blood, 126, 2046, 10.1182/blood.V126.23.2046.2046 Cox, 2015, Therapeutic genome editing: prospects and challenges, Nat Med, 21, 121, 10.1038/nm.3793 Recchia, 2006, Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells, Proc Natl Acad Sci USA, 103, 1457, 10.1073/pnas.0507496103 Hacein-Bey-Abina, 2003, A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency, N Engl J Med, 348, 255, 10.1056/NEJM200301163480314 Lee, 1996, Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif, Int Immunol, 8, 1195, 10.1093/intimm/8.8.1195 Lam, 2005, Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma, J Clin Immunol, 25, 41, 10.1007/s10875-005-0356-5 Slentz-Kesler, 1998, Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms, Genomics, 47, 327, 10.1006/geno.1997.5151 Wang, 2012, K12/SECTM1, an interferon-γ regulated molecule, synergizes with CD28 to costimulate human T cell proliferation, J Leukoc Biol, 91, 449, 10.1189/jlb.1011498 Pace, 2000, CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death, J Immunol, 165, 2331, 10.4049/jimmunol.165.5.2331 Reinhold, 1993, CD7- T cells represent a subset of normal human blood lymphocytes, J Immunol, 150, 2081, 10.4049/jimmunol.150.5.2081 Reinhold, 1996, CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells, Immunology, 89, 391, 10.1046/j.1365-2567.1996.d01-744.x Papadopoulou, 2014, Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT, Sci Transl Med, 6, 242ra83, 10.1126/scitranslmed.3008825 Di Stasi, 2011, Inducible apoptosis as a safety switch for adoptive cell therapy, N Engl J Med, 365, 1673, 10.1056/NEJMoa1106152